Search Login Register

Thromboxane B2 Summary

Description: A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).

Also Known As: B2, Thromboxane; Thromboxa-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,13E,15S)-

Networked: 824 relevant articles (17 outcomes, 69 trials/studies) for this Bio-Agent

Key Diseases for which Thromboxane B2 is Relevant

  1. Ischemia : 1 outcome 2 studies in 39 results
  2. Sepsis (Septicemia) : 1 outcome 2 studies in 17 results
  3. Pulmonary Hypertension (Ayerza Syndrome) : 1 outcome 1 study in 33 results
  4. Asthma (Bronchial Asthma) : 1 outcome 1 study in 13 results
  5. Peripheral Vascular Diseases (Peripheral Vascular Disease) : 1 outcome 1 study in 5 results
Show All >>

Drugs Related to Thromboxane B2

  1. 6-Ketoprostaglandin F1 alpha (6 Ketoprostaglandin F1 alpha)
  2. Aspirin (Acetylsalicylic Acid)
  3. Dinoprostone (PGE2)
  4. Leukotriene B4
  5. Thromboxane A2 (A2, Thromboxane)
  6. Epoprostenol (Prostacyclin)
  7. prostaglandin F1
  8. Histamine (Histamine Dihydrochloride)
  9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  10. Leukotriene E4
Show All >>

Therapies Related to Thromboxane B2

  1. Intravenous Injections
  2. Esophagectomy
  3. Pancreas Transplantation
  4. Thoracotomy
  5. Oral Surgery (Maxillofacial Surgery)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.